Fecal Microbiota Transplantation and Successful Resolution of Multidrug-Resistant-Organism Colonization
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
We report a case in which fecal microbiota transplantation (FMT) utilized for relapsing Clostridium difficile colitis successfully eradicated colonization with several multidrug-resistant organisms (MDROs). FMT may have an additive benefit of reducing MDRO carriage and should be further investigated as a potential measure to eradicate additional potentially virulent organisms beyond C. difficile.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several case reports and animal models have also revealed the probable therapeutic effects of FMT in patients with severe multiple sclerosis, 41 autism, 42 multidrug-resistant organisms (MDRO) infections, 43 and multiple organ dysfunction in critical patients.44”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [43]
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708 · cited 1×
“difficile infections based on case series (3, 4) and, more recently, on a randomized clinical trial (5).”
BackgroundControl of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625 · cited 2×
“The intact human microbiome is a primary host defense for the prevention of the colonization, dominance, and infection of pathogens and pathobionts (6).”
BackgroundMicrobiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564 · cited 1×
“difficile—repopulation with normal intestinal microbiota together with subsequent out-competition of MDROs (7).”
BackgroundTaur, Y., Xavier, J. B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., Lee, Y. J., Dubin, K. A., Socci, N. D., Viale, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis580 · Cited by 1,020 · cited 1×
“Prior studies have shown that the dominance of pathogenic Gram-negative bacteria and enterococcus in the gastrointestinal tract often precedes colonization at other body sites and subsequent infections, especially among critically ill patients (8, 9).”
BackgroundGough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
(1958) · PubMed · Cited by 978
Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., Viale, A., Socci, N. D., van den Brink, M. R. M., Kamboj, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43918 · Cited by 943 · cited 2×
“Since our patient received standard clinical care and treatment, it is difficult to estimate the precise effect of FMT; however, there was a notable temporal decline in MDRO colonization and infections, and studies have shown that decolonization often prevents future infections (9).”
BackgroundKassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Mutation Frequencies and Antibiotic Resistance
Martinez, J. L., & Baquero, F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1771-1777.2000 · Cited by 694
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Research works printed but not linked: 1
- Freedman A, Eppes S. 2014. Use of stool transplantation to clear fecal colonization with carbapenem-resistant Enterobacteriaceae (CRE): proof of concept, abstr 1805. Abstr Soc Healthcare Epidemiol AM (SHEA) IDWeek 2014, 11 October 2014, Philadelphia, PA.
Cited by
Items 101–107 of 107
Lewis, B. (2017) · eCommons (Cornell University)
Evolutionary dynamics of the human gut microbiome
Zhao, S. (2019) · DSpace@MIT (Massachusetts Institute of Technology)
Terapia basada en la microbiota intestinal: terapia de heces
Sánchez Pellicer, C., & Otal Gil, I. (2016) · Zaguan (Universidad de Zaragoza)
91Chapter 4 Probiotics and Gut Microbiota: A Comprehensive Study of Their Interactions and Benefits
Priti, Verma, K., Goyal, S., Praveen, K., Charulata, Gupta, B., & Bansal, P. (2025) · De Gruyter eBooks · doi:10.1515/9783112205150-004
Zhao, X., Lv, Z., Liu, H., & Zhang, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1728176
From Womb to World: Unravelling the Microbiota′s Impact on Health and Disease
Poterico, J. A., Babu, R. V., Jaramillo‐Valverde, L., Sánchez, C., Alayo, E. C., Valdivia‐Silva, J., & Guio, H. (2026) · International Journal of Microbiology · doi:10.1155/ijm/9228548
Metadata
- Authors
- Crum-Cianflone, N. F., Sullivan, E., & Ballon-Landa, G.
- Affiliations
- Infectious Disease Division, Scripps Mercy Hospital, San Diego, California, USA
- Scripps Mercy Hospital (US)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2015-06
- Volume
- 53
- Issue
- 6
- Pages
- 1986-1989
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC4432040
- OpenAlex
- W2160721831
- Cited by
- 103
- References
- 17
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 6 · 2020: 14 · 2019: 18 · 2018: 17 · 2017: 9 · 2016: 12 · 2015: 3
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- fecal microbiota transplantation, multidrug-resistant organisms, Clostridium difficile colitis, MDRO colonization, gut microbiota
- MeSH terms
- Fecal Microbiota Transplantation, Aged, Enterocolitis, Pseudomembranous, Humans, Male, Clostridioides difficile, Fatal Outcome, Drug Resistance, Multiple, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.